Boehringer Ingelheim USA Corporation, Formerly Reported As Boehringer Ingelheim Pharmaceuticals, INC lobbies on its own behalf. For Q3 2026 it reported $1.02M across 1 client report and lists 7 lobbyists across its filings. Issues include Animals, Budget/Appropriations, Health Issues and Medicare/Medicaid.
| Client | Reported | Issues |
|---|---|---|
| BOEHRINGER INGELHEIM USA CORPORATION | $1.02M | Animals, Budget/Appropriations, Health Issues |
| Year | Reported | Clients |
|---|---|---|
| 2026 | $2.90M | 1 |
| 2025 | $3.66M | 1 |
Amounts are the filer's good-faith estimates, per report, and cannot be split by issue. See the Capitol Clarity rankings and method.